JPMorgan Chase & Co’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Buy |
7,953
+7,947
| +132,450% | +$387K | ﹤0.01% | 4171 |
|
|
2025
Q1 | $129 | Hold |
6
| – | – | ﹤0.01% | 5972 |
|
|
2024
Q4 | $161 | Sell |
6
-100
| -94% | -$2.68K | ﹤0.01% | 5886 |
|
|
2024
Q3 | $1.14K | Hold |
106
| – | – | ﹤0.01% | 5640 |
|
|
2024
Q2 | $1.27K | Buy |
106
+83
| +361% | +$991 | ﹤0.01% | 5562 |
|
|
2024
Q1 | $415 | Sell |
23
-49
| -68% | -$884 | ﹤0.01% | 5730 |
|
|
2023
Q4 | $1.14K | Buy |
72
+55
| +324% | +$870 | ﹤0.01% | 5781 |
|
|
2023
Q3 | $315 | Sell |
17
-2
| -11% | -$37 | ﹤0.01% | 5825 |
|
|
2023
Q2 | $432 | Buy |
19
+13
| +217% | +$296 | ﹤0.01% | 5650 |
|
|
2023
Q1 | $0 | Sell |
6
-5
| -45% | – | ﹤0.01% | 5824 |
|
|
2022
Q4 | $0 | Sell |
11
-1
| -8% | – | ﹤0.01% | 5598 |
|
|
2022
Q3 | $0 | Buy |
12
+1
| +9% | – | ﹤0.01% | 5541 |
|
|
2022
Q2 | $0 | Buy |
11
+5
| +83% | – | ﹤0.01% | 5605 |
|
|
2022
Q1 | $0 | Sell |
6
-505
| -99% | – | ﹤0.01% | 5742 |
|
|
2021
Q4 | $13K | Buy |
511
+383
| +299% | +$9.74K | ﹤0.01% | 5391 |
|
|
2021
Q3 | $5K | Sell |
128
-3,056
| -96% | -$119K | ﹤0.01% | 5305 |
|
|
2021
Q2 | $128K | Sell |
3,184
-1,869
| -37% | -$75.1K | ﹤0.01% | 4683 |
|
|
2021
Q1 | $269K | Buy |
5,053
+279
| +6% | +$14.9K | ﹤0.01% | 4343 |
|
|
2020
Q4 | $191K | Buy |
4,774
+4,117
| +627% | +$165K | ﹤0.01% | 4157 |
|
|
2020
Q3 | $38K | Buy |
657
+95
| +17% | +$5.5K | ﹤0.01% | 4356 |
|
|
2020
Q2 | $41K | Buy |
+562
| New | +$41K | ﹤0.01% | 4264 |
|
|
2019
Q4 | – | Sell |
-46
| Closed | -$2K | – | 4702 |
|
|
2019
Q3 | $2K | Sell |
46
-2,347
| -98% | -$102K | ﹤0.01% | 4686 |
|
|
2019
Q2 | $75K | Sell |
2,393
-379
| -14% | -$11.9K | ﹤0.01% | 4107 |
|
|
2019
Q1 | $147K | Sell |
2,772
-3,620
| -57% | -$192K | ﹤0.01% | 3869 |
|
|
2018
Q4 | $300K | Sell |
6,392
-1,061
| -14% | -$49.8K | ﹤0.01% | 3622 |
|
|
2018
Q3 | $656K | Buy |
7,453
+3,500
| +89% | +$308K | ﹤0.01% | 3372 |
|
|
2018
Q2 | $411K | Buy |
3,953
+494
| +14% | +$51.4K | ﹤0.01% | 3532 |
|
|
2018
Q1 | $277K | Buy |
3,459
+1,609
| +87% | +$129K | ﹤0.01% | 3603 |
|
|
2017
Q4 | $252K | Sell |
1,850
-213
| -10% | -$29K | ﹤0.01% | 3584 |
|
|
2017
Q3 | $328K | Buy |
2,063
+900
| +77% | +$143K | ﹤0.01% | 3316 |
|
|
2017
Q2 | $174K | Sell |
1,163
-119
| -9% | -$17.8K | ﹤0.01% | 3428 |
|
|
2017
Q1 | $200K | Buy |
1,282
+1,051
| +455% | +$164K | ﹤0.01% | 3489 |
|
|
2016
Q4 | $48K | Sell |
231
-32
| -12% | -$6.65K | ﹤0.01% | 4030 |
|
|
2016
Q3 | $60K | Sell |
263
-153
| -37% | -$34.9K | ﹤0.01% | 3553 |
|
|
2016
Q2 | $86K | Buy |
416
+410
| +6,833% | +$84.8K | ﹤0.01% | 3401 |
|
|
2016
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 4058 |
|